CTi Biopharma Corp (NASDAQ:CTIC)

1.84
Delayed Data
As of May 04
 +0.05 / +2.79%
Today’s Change
1.72
Today|||52-Week Range
3.23
-22.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.0034.7M60.1M
 
 
 
Cost of Goods Sold0.000.00137.0K895.0K
 
 
 
Depreciation And Amortization2.4M2.3M1.6M1.1M
 
 
 
 
 
 
Operating ExpensesGross Income-2.4M-2.3M33.0M58.1M
 
 
 
 
 
General Expenses70.8M69.1M74.3M119.7M
 
 
 
 
 
Other Operating Expenses0.000.000.002.7M
 
 
Research And Development34.9M33.2M33.6M64.6M
 
 
 
 
 
Total Operating Expenses73.2M71.4M76.0M124.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-73.2M-71.4M-41.4M-64.4M
 
 
 
 
 
Extraordinary Credit11.0M0.000.00--
 
 
Extraordinary Charge0.00-30.1M-155.0K-21.9M
 
 
 
 
Interest Expense On Debt1.6M56.0K1.5M2.7M
 
 
 
 
 
Other Expenses-558.0K-134.0K-485.0K-5.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.6M-101.7M-43.6M-94.2M
 
 
 
 
 
Minority Interest-259.0K-313.0K-807.0K-862.0K
 
 
 
 
 
Preferred Dividend-58.7M-13.9M-6.9M-2.6M
 
 
 
 
 
Net Income-62.4M-101.4M-42.7M-93.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.3M58.1M114.2M148.5M
 
 
 
 
 
Shares To Calculate EPS Diluted34.3M58.1M114.2M148.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.55-$1.98-$0.43-$0.65
 
 
 
 
 
EPS Diluted-$3.55-$1.98-$0.43-$0.65
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account